Stryker: Market Segment Forecasts and Company Strategic Assessment
A strategic assessment of Stryker, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.
Contains 35 pages
Contains 35 pages
SECTION 1: BUSINESS EVOLUTION AND ORGANIZATION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
More Publications
Middle East Diagnostics Market Forecasts 2017-2022: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competitive Strategies, Opportunities for Suppliers
US$ 24,500.00
January 2018
410 pages
LSD Test Volume and Sales Forecasts to 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations
US$ 675.00
June 2017
-
Global Rotavirus Diagnostics Market, 2019-2023: Emerging Opportunities in US, Europe, Japan-Supplier Shares and Strategies, Sales Segment Forecasts, Innovative Technologies and Tests
US$ 4,350.00
June 2019
205 pages
2017 Analysis of Hematology and Flow Cytometry Technologies, and Strategic Profiles of Leading Suppliers
US$ 3,150.00
March 2017
42 pages
Diagnostica Stago --Sales, Market Shares and Competitive Position by Product--USA, Europe, Japan
US$ 3,105.00
June 2017
25 pages
